🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Treatment Approach for Metastatic Intracranial Germinoma: A Multi‐Institutional Experience - Power - Pediatric Blood & Cancer - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/pb…

Our department turned out in droves to see HROP alum, BWH rad onc, and director Roshan Sethi screen his beautiful, hilarious new film A Nice Indian Boy at the sold-out historic Coolidge Corner Theater. We are so proud of Roshan and Karan; get your tickets while you can!

Excited to share the latest study from our group Mass General Cancer Center reporting on proton therapy outcomes for pediatric chordomas and chondrosarcomas. Mass General Brigham Research

In this new Editorial IJROBP - The Red Journal, we discuss the COG Atlas for germ cell tumors and support the recommendation by Alper Kahvecioglu MD and Melek Tugce Yilmaz MD to include the prepontine cistern in the whole ventricular volume. Shannon M MacDonald redjournal.org/article/S0360-… ASTRO

So excited to be part of this organization’s leadership team! We welcome all those interested in joining ARS efforts!

🔇Psssst ... Anthony Zietman is retiring‼️ Keep it a surprise😉We are collecting farewell wishes, anecdotes etc to celebrate his legacy🥳 We are reaching out to many for contributions but feel free to DM/email🙏 Sameer Keole ASTRO Chair Howard Sandler Jeff White kudoboard.com/boards/RLL1u9Oq

Our latest multiD collaboration from the Massachusetts General Hospital studying proton-based therapy for pediatric chordoma and chondrosarcoma of the spine and sacrum. Congrats Myrsini Ioakeim-Ioannidou, MD Shannon M MacDonald for leading this team and ASTRO for highlighting

.Danielle Bitterman, MD, a physician-scientist at Mass General Brigham, joined leading experts at the STAT Breakthrough Summit West yesterday in San Francisco to discuss the future of AI in cancer care. As both a radiation oncologist and AI researcher, she brought a unique

Looking forward to The Particle Therapy Co-Operative Group (PTCOG) next month, where I will be discussing the PARTIQoL trial in a plenary session. 🔬 PARTIQoL is a major win for radiation oncology and, most importantly, for patients. What did the Phase 3 trial comparing proton therapy and IMRT in prostate

🤝 Ensuring access to proton therapy requires more than just technology, it requires collaboration. I emphasize the need for a collaborative model where stakeholders work together to advance research and innovation while reducing disparities in access. Watch the entire

There’s a special kind of pride that grows inside me whenever I see someone from my home institution honored on an international stage. It was a great privilege to hear Dr. Panayiotis Papagelopoulos share “The Hellenic Experience” with treating pelvic tumors Memorial Sloan Kettering Cancer Center

Very happy to join the Annual International Sacro-Pelvic Study Group Meeting at Memorial Sloan Kettering Cancer Center! Grateful for the opportunity to learn from and connect with leading experts across institutions. Inspiring conversations, brilliant minds, and a shared commitment to better care and

X-torial: Cleaning up the misinformation about Joe Biden and #ProstateCancer that I am reading everywhere. The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA National Comprehensive Cancer Network (NCCN) PCa guidelines, hold leadership in NRG Oncology National Cancer Institute

My absolute pleasure to do this! Looking forward to working with the team eContour Erin Gillespie, MD MPH

Excited to be in Buenos Aires for #PTCOG63! Thank you The Particle Therapy Co-Operative Group (PTCOG) for the honor to moderate the CNS/Sarcoma session — join us Friday at 230pm for a great lineup of presentations and discussion. See you there! ☢️🇦🇷✨

Fantastic talk by Dr. Ramesh Rengan Ramesh Rengan at #PTCOG63 on the role of proton therapy in NSCLC. From reirradiation to complex anatomy and immunotherapy combos, protons are a valuable tool in the thoracic oncology arsenal. The Particle Therapy Co-Operative Group (PTCOG) University of Washington Radiation Oncology #ProtonTherapy #LungCancer

Practice-changing data from Dr. Steven Frank Steven J. Frank, MD at #PTCOG63 on head & neck proton therapy. Level 1 evidence shows improved survival, reduced G-tube dependence, and favorable cost-effectiveness vs IMRT. A new standard is taking shape. The Particle Therapy Co-Operative Group (PTCOG) MD Anderson Cancer Center